{"topic":{"slug":"gene-editing-therapies","name":"CRISPR & Gene-Editing Therapies","domain":"medicine","description":"Approved and investigational CRISPR-Cas9 therapies, base and prime editing, in vivo LNP-delivered editing and bespoke editing for ultra-rare disease.","keywords":["CRISPR","base editing","prime editing"],"paper_count":264,"latest_published":"2026-10-26","url":"https://space-kitty.com/topics/gene-editing-therapies","api_url":"https://space-kitty.com/api/v1/topics/gene-editing-therapies"},"dossier":null,"top_papers":[{"id":"doi:10.1038/s41565-020-0669-6","kind":"article","title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing","authors":["Qiang Cheng","Tuo Wei","Lukas Farbiak","Lindsay T. Johnson","Sean A. Dilliard","Daniel J. Siegwart"],"author_count":6,"year":2020,"published":"2020-04-01","venue":"Nature Nanotechnology","cited_by":2370,"doi":"10.1038/s41565-020-0669-6","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41565-020-0669-6","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41565-020-0669-6"},{"id":"doi:10.1056/nejmoa2031054","kind":"article","title":"CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia","authors":["Haydar Frangoul","David Altshuler","Maria Domenica Cappellini","Yi-Shan Chen","Jennifer Domm","Brenda K. Eustace"],"author_count":26,"year":2020,"published":"2020-12-05","venue":"New England Journal of Medicine","cited_by":1960,"doi":"10.1056/nejmoa2031054","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1056/nejmoa2031054","archive_url":"https://space-kitty.com/papers/doi:10.1056/nejmoa2031054"},{"id":"doi:10.1038/s41392-019-0089-y","kind":"review","title":"Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects","authors":["Hongyi Li","Yang Yang","Weiqi Hong","Mengyuan Huang","Min Wu","Xia Zhao"],"author_count":6,"year":2020,"published":"2020-01-03","venue":"Signal Transduction and Targeted Therapy","cited_by":1720,"doi":"10.1038/s41392-019-0089-y","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41392-019-0089-y","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41392-019-0089-y"},{"id":"doi:10.1186/s13756-019-0533-3","kind":"review","title":"Antibiotics versus biofilm: an emerging battleground in microbial communities","authors":["Divakar Sharma","Lama Misba","Asad Ullah Khan"],"author_count":3,"year":2019,"published":"2019-05-16","venue":"Antimicrobial Resistance and Infection Control","cited_by":1560,"doi":"10.1186/s13756-019-0533-3","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1186/s13756-019-0533-3","archive_url":"https://space-kitty.com/papers/doi:10.1186/s13756-019-0533-3"},{"id":"doi:10.1073/pnas.1420294112","kind":"article","title":"Boosting CRISPR/Cas9 multiplex editing capability with the endogenous tRNA-processing system","authors":["Kabin Xie","Bastian Minkenberg","Yinong Yang"],"author_count":3,"year":2015,"published":"2015-03-02","venue":"Proceedings of the National Academy of Sciences","cited_by":1555,"doi":"10.1073/pnas.1420294112","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1073/pnas.1420294112","archive_url":"https://space-kitty.com/papers/doi:10.1073/pnas.1420294112"},{"id":"doi:10.1038/s41580-019-0131-5","kind":"review","title":"The next generation of CRISPR–Cas technologies and applications","authors":["Adrian Pickar‐Oliver","Charles A. Gersbach"],"author_count":2,"year":2019,"published":"2019-05-30","venue":"Nature Reviews Molecular Cell Biology","cited_by":1459,"doi":"10.1038/s41580-019-0131-5","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41580-019-0131-5","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41580-019-0131-5"},{"id":"doi:10.1016/j.cell.2021.09.018","kind":"article","title":"Enhanced prime editing systems by manipulating cellular determinants of editing outcomes","authors":["Chen PJ","Hussmann JA","Yan J","Knipping F","Ravisankar P","Chen PF"],"author_count":14,"year":2021,"published":"2021-10-14","venue":"Cell","cited_by":740,"doi":"10.1016/j.cell.2021.09.018","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/j.cell.2021.09.018","archive_url":"https://space-kitty.com/papers/doi:10.1016/j.cell.2021.09.018"},{"id":"doi:10.1038/nbt.2654","kind":"article","title":"Multiplex and homologous recombination–mediated genome editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9","authors":["Jianfeng Li","Julie Erin Norville","John Aach","Matthew McCormack","Dandan Zhang","Jenifer Bush"],"author_count":8,"year":2013,"published":"2013-08-01","venue":"Nature Biotechnology","cited_by":1511,"doi":"10.1038/nbt.2654","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/nbt.2654","archive_url":"https://space-kitty.com/papers/doi:10.1038/nbt.2654"},{"id":"doi:10.1016/j.cell.2021.12.021","kind":"article","title":"Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins","authors":["Banskota S","Raguram A","Suh S","Du SW","Davis JR","Choi EH"],"author_count":14,"year":2022,"published":"2022-01-11","venue":"Cell","cited_by":562,"doi":"10.1016/j.cell.2021.12.021","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/j.cell.2021.12.021","archive_url":"https://space-kitty.com/papers/doi:10.1016/j.cell.2021.12.021"},{"id":"doi:10.1080/10717544.2018.1474964","kind":"review","title":"Delivering CRISPR: a review of the challenges and approaches","authors":["Christopher A. Lino","Jason C. Harper","James P. Carney","Jerilyn A. Timlin"],"author_count":4,"year":2018,"published":"2018-01-01","venue":"Drug Delivery","cited_by":1184,"doi":"10.1080/10717544.2018.1474964","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1080/10717544.2018.1474964","archive_url":"https://space-kitty.com/papers/doi:10.1080/10717544.2018.1474964"},{"id":"doi:10.1038/nature20565","kind":"article","title":"In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration","authors":["Keiichiro Suzuki","Yuji Tsunekawa","Reyna Hernández‐Benítez","Jun Wu","Jie Zhu","Euiseok J. Kim"],"author_count":35,"year":2016,"published":"2016-11-15","venue":"Nature","cited_by":1149,"doi":"10.1038/nature20565","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/nature20565","archive_url":"https://space-kitty.com/papers/doi:10.1038/nature20565"},{"id":"doi:10.1126/science.aad5143","kind":"article","title":"In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","authors":["Christopher E. Nelson","Chady H. Hakim","David G. Ousterout","Pratiksha I. Thakore","Eirik A. Moreb","Ruth M. Castellanos Rivera"],"author_count":14,"year":2015,"published":"2015-12-31","venue":"Science","cited_by":1143,"doi":"10.1126/science.aad5143","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1126/science.aad5143","archive_url":"https://space-kitty.com/papers/doi:10.1126/science.aad5143"},{"id":"doi:10.1016/j.cell.2022.03.045","kind":"review","title":"Therapeutic in vivo delivery of gene editing agents","authors":["Raguram A","Banskota S","Liu DR"],"author_count":3,"year":2022,"published":"2022-07-06","venue":"Cell","cited_by":459,"doi":"10.1016/j.cell.2022.03.045","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/j.cell.2022.03.045","archive_url":"https://space-kitty.com/papers/doi:10.1016/j.cell.2022.03.045"},{"id":"doi:10.1038/nbt.3659","kind":"article","title":"Applications of CRISPR technologies in research and beyond","authors":["Rodolphe Barrangou","Jennifer A. Doudna"],"author_count":2,"year":2016,"published":"2016-09-01","venue":"Nature Biotechnology","cited_by":1004,"doi":"10.1038/nbt.3659","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/nbt.3659","archive_url":"https://space-kitty.com/papers/doi:10.1038/nbt.3659"},{"id":"doi:10.1038/s41591-018-0050-6","kind":"article","title":"p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells","authors":["Robert J. Ihry","Kathleen A. Worringer","Max R. Salick","Elizabeth Frias","Daniel J. Ho","Kraig M. Theriault"],"author_count":20,"year":2018,"published":"2018-06-08","venue":"Nature Medicine","cited_by":977,"doi":"10.1038/s41591-018-0050-6","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41591-018-0050-6","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41591-018-0050-6"}],"newest_papers":[{"id":"nct:NCT07894887","kind":"trial","title":"EDIT-401 in Adults Who Require Additional Lowering of Low-Density Lipoprotein Cholesterol (LDL-C)","authors":["Editas Medicine, Inc."],"author_count":1,"year":2026,"published":"2026-10-26","venue":"ClinicalTrials.gov","cited_by":null,"doi":null,"arxiv_id":null,"nct_id":"NCT07894887","source_url":"https://clinicaltrials.gov/study/NCT07894887","archive_url":"https://space-kitty.com/papers/nct:NCT07894887"},{"id":"doi:10.1186/s40643-026-01150-0","kind":"article","title":"Base editing-mediated exon-specific knockout of glutamine synthetase generates a high-productivity CHO cell line for antibody manufacturing","authors":["Pu T","Wang C","Lou H","Mi Y","Zhang S","Liu S"],"author_count":10,"year":2026,"published":"2026-10-23","venue":"Bioresources and bioprocessing","cited_by":0,"doi":"10.1186/s40643-026-01150-0","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1186/s40643-026-01150-0","archive_url":"https://space-kitty.com/papers/doi:10.1186/s40643-026-01150-0"},{"id":"nct:NCT07887347","kind":"trial","title":"A Study of the Safety and Efficacy of Prime Editing (PM647a) in Participants With Alpha-1 Antitrypsin Deficiency","authors":["Prime Medicine, Inc."],"author_count":1,"year":2026,"published":"2026-10-21","venue":"ClinicalTrials.gov","cited_by":null,"doi":null,"arxiv_id":null,"nct_id":"NCT07887347","source_url":"https://clinicaltrials.gov/study/NCT07887347","archive_url":"https://space-kitty.com/papers/nct:NCT07887347"},{"id":"doi:10.1002/pld3.70196","kind":"article","title":"Validation of a Modular Base Editing Strategy, Free-BE, in <i>Physcomitrium patens</i>, Maize, and Wheat","authors":["Guyon-Debast A","Javelle M","Perroud PF","Pichon JP","Paul W","Nogué F"],"author_count":6,"year":2026,"published":"2026-10-15","venue":"Plant direct","cited_by":0,"doi":"10.1002/pld3.70196","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1002/pld3.70196","archive_url":"https://space-kitty.com/papers/doi:10.1002/pld3.70196"},{"id":"doi:10.1038/s41467-026-78344-9","kind":"article","title":"cPRIME enables endogenous mapping of genetic variant effects at RNA level","authors":["El Kassem G","Westphal C","Doebel M","Hillmer J","Seifert T","Boettcher M"],"author_count":6,"year":2026,"published":"2026-10-15","venue":"Nature communications","cited_by":0,"doi":"10.1038/s41467-026-78344-9","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41467-026-78344-9","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41467-026-78344-9"},{"id":"doi:10.7759/cureus.117975","kind":"article","title":"Individualized and Platform-Designated Gene-Editing Studies in the Registered Clinical Record: A Case-by-Case Census Against 148 Eligible Studies","authors":["Li OM","Li Y"],"author_count":2,"year":2026,"published":"2026-10-15","venue":"Cureus","cited_by":0,"doi":"10.7759/cureus.117975","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.7759/cureus.117975","archive_url":"https://space-kitty.com/papers/doi:10.7759/cureus.117975"},{"id":"doi:10.1002/advs.78309","kind":"review","title":"Mitochondrial Quality Control in Degenerative Musculoskeletal Diseases: Signaling Networks and Therapeutic Landscapes","authors":["Gao H","Cheng Z","Chen X","Wu W","Yu Z","Yang C"],"author_count":7,"year":2026,"published":"2026-10-14","venue":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","cited_by":0,"doi":"10.1002/advs.78309","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1002/advs.78309","archive_url":"https://space-kitty.com/papers/doi:10.1002/advs.78309"},{"id":"arxiv:2610.04763","kind":"preprint","title":"Tracing model-generated DNA with position-independent watermarking","authors":["Kimon Antonios Provatas1","Christos Galanopoulos","Ilias Georgakopoulos-Soares"],"author_count":3,"year":2026,"published":"2026-10-03","venue":null,"cited_by":0,"doi":null,"arxiv_id":"2610.04763","nct_id":null,"source_url":"https://arxiv.org/abs/2610.04763","archive_url":"https://space-kitty.com/papers/arxiv:2610.04763"},{"id":"doi:10.1093/nar/gkag990","kind":"article","title":"Chemically stabilized long antisense oligonucleotides perturb RNA exosome function","authors":["Hofacker DT","Gackstatter S","Deisling V","Stafforst T"],"author_count":4,"year":2026,"published":"2026-10-01","venue":"Nucleic acids research","cited_by":0,"doi":"10.1093/nar/gkag990","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1093/nar/gkag990","archive_url":"https://space-kitty.com/papers/doi:10.1093/nar/gkag990"},{"id":"pmc:PMC13670207","kind":"article","title":"Validation of a Modular Base Editing Strategy, Free‐BE, in Physcomitrium patens, Maize, and Wheat","authors":["Guyon‐Debast A","Javelle M","Perroud P","Pichon J","Paul W","Nogué F"],"author_count":6,"year":2026,"published":"2026-10-01","venue":"Plant direct","cited_by":0,"doi":null,"arxiv_id":null,"nct_id":null,"source_url":"https://europepmc.org/article/PMC/PMC13670207","archive_url":"https://space-kitty.com/papers/pmc:PMC13670207"}],"related_topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","api_url":"https://space-kitty.com/api/v1/topics/cancer-immunotherapy"},{"slug":"mrna-cancer-vaccines","name":"mRNA Therapeutics & Cancer Vaccines","api_url":"https://space-kitty.com/api/v1/topics/mrna-cancer-vaccines"},{"slug":"gene-cell-therapy","name":"Gene & Cell Therapy","api_url":"https://space-kitty.com/api/v1/topics/gene-cell-therapy"},{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","api_url":"https://space-kitty.com/api/v1/topics/glp1-metabolic"},{"slug":"neurodegeneration","name":"Alzheimer's, Parkinson's & Neurodegeneration","api_url":"https://space-kitty.com/api/v1/topics/neurodegeneration"},{"slug":"aging-longevity","name":"Biology of Aging & Longevity","api_url":"https://space-kitty.com/api/v1/topics/aging-longevity"},{"slug":"infectious-disease-amr","name":"Infectious Disease, Vaccines & Antimicrobial Resistance","api_url":"https://space-kitty.com/api/v1/topics/infectious-disease-amr"},{"slug":"ai-medicine","name":"AI in Clinical Medicine","api_url":"https://space-kitty.com/api/v1/topics/ai-medicine"},{"slug":"cardiovascular-innovation","name":"Cardiovascular Therapeutics","api_url":"https://space-kitty.com/api/v1/topics/cardiovascular-innovation"}],"premium":{"dossier":null,"research_pack":{"url":"https://space-kitty.com/api/v1/topics/gene-editing-therapies/pack","price_usd":"0.20"}},"more":"https://space-kitty.com/api/v1/topics/gene-editing-therapies/papers?sort=top&limit=100"}